Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The first quarter of 2026 started with optimism ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior leadership will parti ...

Q2 FY26 earnings call highlights: raised revenue guide, AI-enabled drug discovery, AWS partnership, margin and EBITDA outlook.

Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Mid Cap ...

JUNCTION CITY, Kan.--(BUSINESS WIRE)--Ventria Bioscience Inc. (Ventria) today announced that the United States International Trade Commission (ITC) completed its review of Administrative Law Judge ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today expanded its clonal genes portfolio with the early access launch of Complex Genes. “As research in ...

(Editor’s note: This story has been updated to include NAGE stock movement) Niagen Bioscience NAGE, the maker of anti-ageing ...

Tru Niagen is expanding its patented nicotinamide riboside, known as Niagen, into skincare and beauty supplements. Driven by ...

View Twist Bioscience Corp. TWST stock quote prices, financial information, real-time forecasts, and company news from CNN.

Niagen Bioscience, Inc. (NASDAQ: NAGE) is the global authority in NAD+ (nicotinamide adenine dinucleotide) science and ...

The CEO of the controversial firm says the new service is possible to due its existing technology, plus increased capacity at the Wilsonville facility Earlier this week, the Wilsonville-based biotech ...

Humans wiped out the bluebuck in Africa around 200 years ago. Bringing it back is both ethically and technologically ...